New drug cocktail tested for Tough-to-Treat stomach cancer
NCT ID NCT04209686
Summary
This study is testing whether combining three drugs—paclitaxel, pembrolizumab, and olaparib—is safe and can help control advanced stomach cancer. It is for people whose cancer has continued to grow after trying one prior treatment. The main goal is to see if this combination helps patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.